Related Experiment Videos
Socio-demographic features of cannabis and heroin abuse in Bombay
Journal of Postgraduate Medicine
|October 1, 1989
Abstract:
A study of socio-demographic features of 680 cannabis and heroin addicts showed that the factors like, age, religion, family structure, peer groups and the easy availability of these drugs contribute to the problem of addiction.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Community-based tobacco cessation program among women in Mumbai, India.
Indian journal of cancer·2014
Compliance to Gutka ban and other provisons of COTPA in Mumbai.
Indian journal of cancer·2014
Impact of 'gutkha and pan masala ban' in the state of Maharashtra on users and vendors.
Indian journal of cancer·2014
From traumatic necrotizing fasciitis to central nervous system involvement: Expanding the clinical spectrum of Apophysomyces variabilis.
Journal of postgraduate medicine·2026
Diagnostic utility of the urine lipoarabinomannan assay for tuberculosis screening in patients with diabetes mellitus.
Journal of postgraduate medicine·2026
When enough is enough: Understanding saturation in qualitative research.
Journal of postgraduate medicine·2026
A pathological analysis of pediatric pulmonary cystic/cavitary lesions.
Journal of postgraduate medicine·2026
POEMS syndrome with atypical presentation: A rare case.
Journal of postgraduate medicine·2026
Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study.
European journal of dermatology : EJD·2026
Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.
European journal of dermatology : EJD·2026
Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1.
Journal of acquired immune deficiency syndromes (1999)·2026
Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.
Brain : a journal of neurology·2026